JF
ADVM

Jump Financial’s Adverum Biotechnologies ADVM Stock Holding History

Jump Financial’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,203
Closed -$166K – 1598
2024
Q2 		$166K Buy
+24,203
New +$225K ﹤0.01% 1583
2021
Q4 		– Sell
-2,660
Closed -$58K – 1343
2021
Q3 		$58K Buy
2,660
+1,436
+117% +$36.6K ﹤0.01% 1022
2021
Q2 		$43K Sell
1,224
-3,058
-71% -$165K ﹤0.01% 1032
2021
Q1 		$422K Buy
4,282
+1,632
+62% +$196K 0.04% 469
2020
Q4 		$287K Sell
2,650
-1,572
-37% -$194K 0.05% 613
2020
Q3 		$434K Buy
+4,222
New +$632K 0.09% 374

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Jump Financial's ADVM Position: Q3 2024 in Review

Jump Financial sold out of Adverum Biotechnologies (ADVM) in Q3 2024, closing a stake of 24,203 shares — an estimated $166K sold.

Jump Financial first reported a position in ADVM in Q3 2020 and held it in 6 quarters. The position peaked at $434K in Q3 2020. 77 funds tracked by Wall St. Rank hold ADVM as of Q3 2024.

  • Jump Financial reported no remaining Adverum Biotechnologies position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 24,203 Adverum Biotechnologies shares in Q3 2024, an estimated $166K.
  • Jump Financial first reported a position in Adverum Biotechnologies in Q3 2020 and held it in 6 quarters.
  • Jump Financial's Adverum Biotechnologies position peaked at $434K in Q3 2020.
  • 77 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.